Back to search

The under-recognized role of dopamine in the treatment of major depressive disorder

Data up to Jan 2025

Published2008
Citations29
References63

Total Citations Per Year

Abstract

References (63)

Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States

1994 • 12,456 citations

The Epidemiology of Major Depressive Disorder

2003 • 7,767 citations

Epidemiology of Major Depressive Disorder

2005 • 1,620 citations

Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

2003 • 891 citations

A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression

2005 • 860 citations

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

2001 • 818 citations

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

2005 • 606 citations

Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression

2006 • 555 citations

Depression in the community

1997 • 500 citations

SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants

2005 • 439 citations

Modern antipsychotic drugs: a critical overview

2005 • 414 citations

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder

2007 • 399 citations

Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study

1990 • 390 citations

The pharmacological treatment of delusional depression

1985 • 356 citations

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder

2002 • 334 citations

Duloxetine in the Treatment of Depression

2004 • 317 citations

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia

1994 • 301 citations

Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study

1986 • 294 citations

An overview of the mechanism of action of clozapine.

1994 • 283 citations

Risperidone Augmentation of Selective Serotonin Reuptake Inhibitors in Major Depression

1999 • 249 citations

Response and Remission Rates in Different Subpopulations With Major Depressive Disorder Administered Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Placebo

2001 • 245 citations

Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.

1998 • 243 citations

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

2006 • 227 citations

A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder

2007 • 219 citations

A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors

2004 • 214 citations

Pharmacological prevention of suicidal behaviour

1982 • 210 citations

The role of dopamine and norepinephrine in depression and antidepressant treatment.

2006 • 209 citations

Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine

2004 • 187 citations

A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

2004 • 179 citations

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

2006 • 173 citations

Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression

2005 • 166 citations

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

2004 • 153 citations

Effects of Risperidone Augmentation in Patients with Treatment-Resistant Depression: Results of Open-Label Treatment Followed by Double-Blind Continuation

2006 • 145 citations

Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

2005 • 125 citations

Aripiprazole Augmentation of Selective Serotonin Reuptake Inhibitors for Treatment-Resistant Major Depressive Disorder

2005 • 124 citations

Olanzapine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder

2000 • 105 citations

Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission A double-blind, comparative study

1998 • 102 citations

Aripiprazole Augmentation of Antidepressants for the Treatment of Partially Responding and Nonresponding Patients With Major Depressive Disorder

2005 • 100 citations

Clinical update on amisulpride in deficit schizophrenia

1997 • 93 citations

Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis

2006 • 92 citations

Atypical Antipsychotics: Matching Receptor Profile to Individual Patient's Clinical Profile

2004 • 92 citations

Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD).

1996 • 89 citations

Risperidone augmentation in refractory obsessive—compulsive disorder: an open-label study

2000 • 84 citations

Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder

2005 • 82 citations

Quetiapine augmentation of treatment-resistant depression: a comparison with lithium

2007 • 80 citations

Social functioning and quality of life in the schizophrenic patient: advantages of amisulpride

2002 • 75 citations

Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation

2005 • 68 citations

Amisulpiride augmentation in treatment resistant obsessive–compulsive disorder: an open trial

2003 • 66 citations

Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study

2002 • 63 citations

An Open-Label, Rater-Blinded, Augmentation Study of Aripiprazole in Treatment-Resistant Depression

2006 • 60 citations

A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder

2006 • 59 citations

Antidepressant Action of Sulpiride. Results of a Placebo-Controlled Double-Blind Trial

1999 • 52 citations

Rapid onset of action of venlafaxine

1995 • 52 citations

Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study

2001 • 51 citations

Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study

2005 • 51 citations

A Metaanalysis of Clinical Trials Comparing Moclobemide with Selective Serotonin Reuptake Inhibitors for the Treatment of Major Depressive Disorder

2006 • 51 citations

Consensus on the Use of Substituted Benzamides in Psychiatric Patients

2004 • 47 citations

Quetiapine Augmentation in Obsessive-Compulsive Disorder Resistant to Serotonin Reuptake Inhibitors

2005 • 45 citations

An Open Study of Olanzapine and Fluoxetine for Psychotic Major Depressive Disorder

2002 • 44 citations

Adjunctive Quetiapine for Treatment-Resistant Adolescent Major Depressive Disorder: ACase Series

2005 • 40 citations

Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients

1998 • 36 citations

Antidepressant efficacy of olanzapine as monotherapy in major depressive disorder, without psychosis: A pilot study

2006 • 16 citations

Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: A multicenter trial in general practice

1992 • 11 citations

Cited By (0)

Loading...